Tumor neoantigen-based T cell sorting preparation technology and application thereof
A cell and new technology, applied in the field of molecular biology, can solve the problems of insufficient purity, affecting the therapeutic effect, and impurity of cells
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0025] The present invention provides a method for preparing T cells based on tumor neoantigens, and the method for preparing T cells based on tumor neoantigens includes the following steps:
[0026] S1: Collect tumor specimens, analyze tumor gene mutations by gene sequencing, and collect patient tumor tissue by means of surgery, puncture, intervention, etc.; sequence and detect gene mutations by methods such as whole exome sequencing, probe recovery sequencing, etc.;
[0027] S2: Analyze tumor neoantigens based on gene mutation, and analyze tumor neoantigens based on gene mutation, HLA affinity, gene expression and other information;
[0028] S3: prepare a neoantigen vaccine according to the neoantigen, and prepare a polypeptide or RNA vaccine according to the neoantigen sequence;
[0029] S4: collect peripheral blood cells from patients, separate DC cells and T cells;
[0030] S5: Induce and stimulate DC cells with tumor neoantigen vaccine, and transfer polypeptide vaccine ...
Embodiment 1
[0038] This example is used to illustrate the method for sorting and preparing NRT according to the present invention;
[0039] Raw materials: tumor tissue, PBMC, DC cells, T cells, tumor neoantigen vaccine;
[0040] NRT sorting preparation method:
[0041] (1) Collect patient tissue samples, analyze gene mutations by gene sequencing, analyze tumor neoantigens according to the mutations, and prepare tumor neoantigen vaccines according to the results of neoantigen analysis;
[0042] (2) Isolation and culture of PBMC cells in peripheral blood of patients: after centrifuging 50ml of white blood cells collected by the apheresis machine to remove the plasma, add 50ml of normal saline to dilute, and mix gently;
[0043] Take two 50ml centrifuge tubes, first add 15ml Ficoll solution, and then gently add the diluted blood to the upper layer of Ficoll in the two centrifuge tubes, be gentle to avoid mixing the two solutions together, each centrifuge tube has 30ml of diluted blood ;2,000...
Embodiment 2
[0054] This example is used to illustrate the comparison of the killing effect of sorted NRT and non-sorted NRT:
[0055] 1: Prepare and sort 41BB positive T cells and T cells without sorting according to the above method;
[0056] 2: In vitro expansion of the above T cells;
[0057] 3: In vitro killing experiment: the T cells prepared above were co-incubated with tumor cells prepared from the patient's own tumor tissue, and the killing effect was detected by LDH release method.
[0058] Based on the above, the vaccine is prepared according to tumor neoantigens by sorting technology, and then the vaccine is transferred into antigen-presenting cells, and the activation of T cells is induced by co-incubation of antigen-presenting cells and T cells. The selected technology, the prepared cells can be used in the treatment or prevention of tumor drugs, and the NRT cells are sorted out based on tumor neoantigens to obtain pure NRT cells, which can be used for subsequent cell therap...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com